The international explosion of mobile & digital health: fresh approaches for managing content, culture and global markets Registration

Date:9/28/2021

Time:1:00 PM EDT

Duration:60 minutes

The COVID-19 pandemic has done much to propel digital disruption forward, and life sciences companies need to lean into that trend across a range of areas — from patient engagement and recruitment, to continuous health monitoring and remote treatment using smart medical devices linked to apps or online portals. This is especially the case as healthcare markets continue to plan for the new normal, and the role continued remote care and monitoring will play in ongoing treatment models. However, managing all of this across global markets is not without its challenges. Approaches and content must be adapted to suit each market, culture and language, so that services are consistent and reliable for all patients. This isn’t just about the language and phrasing used, but about data gathering, normalization and analysis in a global context unit of measurement and other reporting elements that need to be localized. This webinar will explore how best to respond to these requirements in the face of booming digital health, while maximizing opportunities for innovation across pharma and devices.

If you're already registered for the "The international explosion of mobile & digital health: fresh approaches for managing content, culture and global markets" webcast, click below:

ALREADY REGISTERED?

Speakers

Heather Reilly

Director, quality analytics

Janssen, Pharmaceutical Company of Johnson & Johnson

Heather Reilly is a disruptor and change agent with an exceptional and diverse 20+ year career in the pharmaceuticals, consumer and medical device industries. Her vision is to transform data into risk-based insights and to harness innovative tools to deliver proactive quality while driving top compliance. This is done by blending her passion, knowledge of science and ingenuity to profoundly change the trajectory of health for humanity. She has capitalized on being a 20-year veteran of Johnson and Johnson by leaning into different opportunities across its vast and diverse portfolio. Reilly brings her passion of encouraging young women to a STEM career in servicing the committee as a Board of Trustee to the Princeton-Blairstown Center. She holds a bachelor’s degree in chemistry and a master of science in quality systems management.

Leigh Ann Soltysiak, M.S.

Founder, principal

Silverleaf Consulting

Leigh Soltysiak has over 25 years of experience within the healthcare /life-sciences industry, specializing in commercialization /new product development, launch strategy and marketing/sales execution. She advises startup and established companies on how to achieve success throughout the critical product and brand developmental milestones: customer insights mining/research, problem/product ideation, value proposition creation, target product profile, market analytics, market development and access, global launch strategy, integrated marketing planning, strategic sales execution, life-cycle plan, portfolio planning, business development and more. Prior to Silverleaf, she was a 19-year veteran of Johnson & Johnson within the biotech, medical device and pharmaceutical sectors, serving across all facets of commercialization including product specialty sales, institutional account sales/ management, district sales manager, brand management, global commercial leader/global strategic marketing and global launch leadership roles. She worked across white space, novel therapeutics and flagship brands in specialty areas such as hematology oncology, HIV/infectious disease, chronic kidney disease, women's health, CV/stroke and medtech/robotics. During her tenure, she earned multiple awards, recognized for her exceptional strategic, brand execution and sales leadership performance.

Kathleen O’Brien

Director of business development

Amplexor Life Sciences

Kathleen O’Brien is director of business development with Amplexor Life Sciences and a 17-year veteran of the translation industry. Kathleen has a background in linguistics and has held various roles in the translation business: vendor, project and account management, as well as new business development, giving her a unique perspective into both translation operations and how translation impacts the globalization needs of her clients in the pharmaceutical and medical device industries. She proactively collaborates with her life sciences client partners on a daily basis to help them set their globalization content strategies.